Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pregabablin Open-Label, Follow-On Safety Trial In Patients With Refractory Partial Epilepsy.

NCT00141414 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00141414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00141414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pregabablin Open-Label, Follow-On Safety Trial In Patients With Refractory Partial Epilepsy.
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
November 30, 1997
Completion date
October 31, 2005
Enrollment
82
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, partial